tiprankstipranks
Advertisement
Advertisement

AQST Stock Latest News

Aquestive Therapeutics Earnings Call Highlights Anaphylm Progress
Company AnnouncementsAquestive Therapeutics Earnings Call Highlights Anaphylm Progress
3d ago
AQST
Aquestive Advances Anaphylm Program and Q2 2026 Results
PremiumCompany Announcements
Aquestive Advances Anaphylm Program and Q2 2026 Results
12d ago
8K
AQST
Aquestive Therapeutics reports Q2 EPS (18c), consensus (12c)
PremiumThe Fly
Aquestive Therapeutics reports Q2 EPS (18c), consensus (12c)
12d ago
AQST
Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $50.51M
PremiumThe Fly
Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $50.51M
12d ago
AQST
Aquestive Therapeutics options imply 6.1% move in share price post-earnings
PremiumThe Fly
Aquestive Therapeutics options imply 6.1% move in share price post-earnings
12d ago
AQST
Aquestive Advances Anaphylm With Positive Study Results
PremiumCompany AnnouncementsAquestive Advances Anaphylm With Positive Study Results
13d ago
8K
AQST
Aquestive Therapeutics, Inc. (AQST) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Aquestive Therapeutics, Inc. (AQST) Q2 Earnings Cheat Sheet
15d ago
AQST
Aquestive Therapeutics files to sell 230,271 shares of common stock for holders
Premium
The Fly
Aquestive Therapeutics files to sell 230,271 shares of common stock for holders
2M ago
AQST
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
PremiumRatings
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
2M ago
AQST
Aquestive Shareholders Back Directors, Pay Plan, Auditor
PremiumCompany Announcements
Aquestive Shareholders Back Directors, Pay Plan, Auditor
2M ago
8K
AQST
Aquestive Therapeutics Charts Cautious, Liquid Path Forward
PremiumCompany Announcements
Aquestive Therapeutics Charts Cautious, Liquid Path Forward
3M ago
AQST
Aquestive Therapeutics Signals Momentum In Earnings Call
PremiumCompany Announcements
Aquestive Therapeutics Signals Momentum In Earnings Call
3M ago
AQST
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
PremiumThe FlyMidday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
3M ago
AEM
FNV
Aquestive Secures New Oaktree Term Loan to Fund Anaphylm
Premium
Company Announcements
Aquestive Secures New Oaktree Term Loan to Fund Anaphylm
3M ago
8K
AQST
Aquestive Therapeutics reports Q1 EPS (7c), consensus (13c)
Premium
The Fly
Aquestive Therapeutics reports Q1 EPS (7c), consensus (13c)
3M ago
AQST
Aquestive Therapeutics options imply 7.1% move in share price post-earnings
PremiumThe Fly
Aquestive Therapeutics options imply 7.1% move in share price post-earnings
3M ago
AQST
AQST Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AQST Upcoming Earnings Report: What to Expect?
3M ago
AQST
Aquestive Therapeutics assumed with an Outperform at Oppenheimer
PremiumThe Fly
Aquestive Therapeutics assumed with an Outperform at Oppenheimer
4M ago
AQST
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
PremiumMarket News
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
4M ago
AQST
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
PremiumClass ActionAquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
5M ago
AQST
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
Premium
Company Announcements
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
5M ago
8K
AQST
Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA
Premium
The Fly
Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA
5M ago
AQST

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >